Filing Details
- Accession Number:
- 0000899243-18-014656
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-01 14:37:21
- Reporting Period:
- 2018-05-29
- Accepted Time:
- 2018-06-01 14:37:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1537917 | Tyme Technologies Inc. | TYME | Pharmaceutical Preparations (2834) | 453864597 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1712467 | Michael Demurjian | C/O Tyme Technologies, Inc. 17 State Street - 7Th Floor New York NY 10004 | Chief Operating Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-05-29 | 8,382 | $3.75 | 26,669,754 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 9, 2018.
Billionaire Hedge Funds
